Cyclarity Therapeutics

📍 Novato, United States👥 18 employees💰 Last funded Feb 2026
Cyclarity Therapeutics, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.
6
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography4 countries
France
2
United States
2
New Zealand
1
Mexico
1
Investor activity2023–2026 · investors recorded per year
20231202422025220261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cyclarity Therapeutics?
Cyclarity Therapeutics has 6 investors on record on gritt.io.
When did Cyclarity Therapeutics last raise funding?
The most recent investment in Cyclarity Therapeutics recorded on gritt.io was in February 2026.
What industry is Cyclarity Therapeutics in?
Cyclarity Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cyclarity Therapeutics based?
Cyclarity Therapeutics is headquartered in Novato, United States.